These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6994733)

  • 1. Bacterial mutagenesis and host cell DNA damage by chemical carcinogens in the Salmonella/hepatocyte system.
    Staiano N; Erickson LC; Thorgeirsson SS
    Biochem Biophys Res Commun; 1980 Jun; 94(3):837-42. PubMed ID: 6994733
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
    Weeks CE; Allaben WT; Louie SC; Lazear EJ; King CM
    Cancer Res; 1978 Mar; 38(3):613-8. PubMed ID: 203386
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of conjugation reactions on the mutagenicity of aromatic amines.
    Hongslo J; Haug LT; Wirth PJ; Møller M; Dybing E; Thorgeirsson SS
    Mutat Res; 1983 Feb; 107(2):239-47. PubMed ID: 6346076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems.
    Bartsch H; Malaveille C; Camus AM; Martel-Planche G; Brun G; Hautefeuille A; Sabadie N; Barbin A; Kuroki T; Drevon C; Piccoli C; Montesano R
    Mutat Res; 1980 Jul; 76(1):1-50. PubMed ID: 6993936
    [No Abstract]   [Full Text] [Related]  

  • 5. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium.
    Castro CE; Felkner IC; Yang SP
    Cancer Res; 1978 Sep; 38(9):2836-41. PubMed ID: 354780
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential.
    McGregor D
    Mutat Res; 1975 Dec; 30(3):305-15. PubMed ID: 1105163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-acetylaminofluorene-induced unscheduled DNA synthesis in hepatocytes isolated from 3-methylcholanthrene treated rats.
    Casciano DA; Farr JA; Oldham JW; Cave MD
    Cancer Lett; 1978 Sep; 5(3):173-8. PubMed ID: 688198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
    Hinson JA; Andrews LS; Gillette JR
    Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutagenicity of 7-iodo and 7-fluoro derivatives of N-hydroxy-and N-acetoxy-N-2-acetylaminofluorene in the Salmonella typhimurium assay.
    Santella RM; Fuchs RP; Grunberger D
    Mutat Res; 1979 May; 67(1):85-7. PubMed ID: 379638
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA repair in primary cultures of rat hepatocytes.
    Yager JD; Miller JA
    Cancer Res; 1978 Dec; 38(12):4385-94. PubMed ID: 719626
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistic effect of diethylstilbestrol on the mutagenicity of 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene in the Salmonella assay system.
    Allaben WT; Louie SC; Lazear EJ
    Cancer Lett; 1979 Jul; 7(2-3):109-14. PubMed ID: 476604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of disulfiram on mutagenicity of the urinary metabolites of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in the Salmonella test system.
    El-Torkey NM; Weisburger EK
    Mutat Res; 1983 Jul; 118(1-2):1-6. PubMed ID: 6346083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of reducing agents on N-acetoxy- and N-hydroxy-2-acetylaminofluorene-induced mutagenesis.
    Rosin MP; Stich HF
    Cancer Res; 1978 May; 38(5):1307-10. PubMed ID: 346207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives.
    Jacobs MM; Matney TS; Griffin AC
    Cancer Lett; 1977 May; 2(6):319-22. PubMed ID: 324608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene.
    Beranek DT; White GL; Heflich RH; Beland FA
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5175-8. PubMed ID: 6752940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of the dye intermediates Michler's ketone and methane base to rat liver nucleic acids and lack of mutagenicity in Salmonella typhimurium.
    Scribner JD; Koponen G; Fisk SR; Woodworth B
    Cancer Lett; 1980 Apr; 9(2):117-21. PubMed ID: 6155205
    [No Abstract]   [Full Text] [Related]  

  • 17. Macromolecular complexes produced by chemical carcinogens and ultraviolet radiation.
    Morin NR; Zeldin PE; Kubinski ZO; Bhattacharya PK; Kubinski H
    Cancer Res; 1977 Oct; 37(10):3802-14. PubMed ID: 332339
    [No Abstract]   [Full Text] [Related]  

  • 18. Activatin of guanylate cyclase during the oxidation of arylamine carcinogens.
    DeRubertis FR; Craven PA
    Biochem Biophys Res Commun; 1979 Jul; 89(2):464-73. PubMed ID: 39558
    [No Abstract]   [Full Text] [Related]  

  • 19. N-hydroxy-2-acetylaminofluorene as effective inhibitor of aldehyde oxidase.
    Tatsumi K; Kitamura S
    Biochem Biophys Res Commun; 1986 Jul; 138(1):312-7. PubMed ID: 3741414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
    Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM
    Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.